Research Progress of Eukaryotic Translation Initiation Factor 2α in Kidney Diseases
Author:
Affiliation:

Shanghai Laboratory Anti-doping, Shanghai University of Sport, Shanghai 200438, China

Clc Number:

Fund Project:

This work was supported by a grant from The National Natural Science Foundation of China (81370197).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    The prevention and treatment of kidney disease has been a focus of medical research.Eukaryotic translation initiation factor 2α (eIF2α) is a key factor in the metabolic stress response of mammalian cells, inducing inhibition of overall protein translation, restoring protein synthesis and controlling cell survival under different cellular metabolic stresses, and its kinase plays an important role in maintaining normal physiological functions of the body as well as in the development of tumor, immune and metabolism-related diseases. It is suggested that eIF2α kinase may be involved in the pathological process of several renal diseases. Therefore, this paper summarizes the research progress on eIF2α kinase family and its possible role in renal diseases, in order to provide a new theoretical basis and reference for the prevention and treatment of renal diseases.

    Reference
    Related
    Cited by
Get Citation

ZHENG Xiao-Ci, WU Die, XU Xin. Research Progress of Eukaryotic Translation Initiation Factor 2α in Kidney Diseases[J]. Progress in Biochemistry and Biophysics,2022,49(8):1453-1461

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:September 03,2021
  • Revised:December 02,2021
  • Accepted:December 09,2021
  • Online: August 19,2022
  • Published: August 20,2022